Thrilled to share this work, now out in
@JournalCancer
Expert consensus statement on the use of incretin mimetics in patients with NENs, eloquently summarized by
@OncoThor in the tweet below. Grateful to be a part of this effort. This statement not only provides guidance/expert advice on tackling this challenge in clinic when seeing patients but also highlights the need for robust prospective evidence to guide future use of these agents.
@NANETS1 @ENETS_ORG @WinshipAtEmory